NRx Pharmaceuticals

NRx Pharmaceuticals and Nephron Pharmaceuticals Announce Joint Agreement to Develop Intravenous Ketamine to Treat Suicidal Depression

RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and Nephron Pharmaceuticals, Inc. announced the recent signing of a development and manufacturing agreement to manufacture a presentation of ketamine suitable for …

NRx Pharmaceuticals and Nephron Pharmaceuticals Announce Joint Agreement to Develop Intravenous Ketamine to Treat Suicidal Depression Read More
Lincoln Financial Group

Lincoln Financial Group Receives Regulatory Approval for Reinsurance Transaction With Fortitude Re

RADNOR, PA — Lincoln Financial Group (NYSE: LNC) announced that it recently received regulatory approval late yesterday for its previously announced reinsurance transaction with Fortitude Reinsurance Company Ltd. (“Fortitude Re”). …

Lincoln Financial Group Receives Regulatory Approval for Reinsurance Transaction With Fortitude Re Read More